(Q35179432)

7 August 2017

1 reference

title

Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancer (English)

1 reference

7 August 2017

1 reference

5

David R Gandara

1 reference

7 August 2017

Philip C Mack

1

1 reference

7 August 2017

Angela M Davies

series ordinal

2

1 reference

7 August 2017

Primo N Lara

series ordinal

3

1 reference

7 August 2017

Paul H Gumerlock

series ordinal

4

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

41 Suppl 1

1 reference

7 August 2017

page(s)

S89-96

1 reference

Roles of ubiquitin-mediated proteolysis in cell cycle control

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Endoproteolytic activity of the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Development of the proteasome inhibitor PS-341.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Proteasome inhibition: a new strategy in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Molecular-clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

High cyclin E and low p27/Kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Proteasome-dependent regulation of p21WAF1/CIP1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

P53: an ubiquitous target of anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

p53-dependent induction of apoptosis by proteasome inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Expression of bcl-2--protein in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

An information-intensive approach to the molecular pharmacology of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Molecular pathways that modify tumor radiation response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900149-1

7 January 2021

10.1016/S0169-5002(03)00149-1

Identifiers

DOI

1 reference

7 August 2017

1 reference